Ayodele Olumide Erinle MD FACP

Internal Medicine•Gallup, NM

Geriatric Medicine, Hospital Medicine/Hospitalist, Nephrology

High Desert Nephrology Associates

Join to View Full Profile

1801 Redrock DrGallup, NM 87301
Phone+1 505-863-7993
Fax+1 505-863-9406

Summary

Dr. Ayodele Erinle is a nephrologist in Gallup, NM and is affiliated with multiple hospitals in the area, including Gallup Indian Medical Center, University of New Mexico Hospitals, and Rehoboth McKinley Christian Health Care Services. He received his medical degree from University of Lagos College of Medicine and has been in practice 21 years. He is experienced in hypertension, general nephrology, acute renal failure, chronic kidney disease, interventional nephrology, and investigational new drug research.

Education & Training

University of Texas Medical Branch HospitalsFellowship, Nephrology, 2006 - 2008
UPMC Medical Education Prog2005 - 2006
St Agnes HealthCareResidency, Internal Medicine, 2002 - 2005
University of Lagos College of MedicineClass of 1996

Certifications & Licensure

NM State Medical License 2007 - 2026
SC State Medical License 2020 - 2023
MD State Medical License 2004 - 2008
PA State Medical License 2005 - 2008

Awards, Honors, & Recognition

Fellow (FACP) American College of Physicians, 2011

Clinical Trials

Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis Participants Start of enrollment: 2014 Feb 11
Completed
Phase 3
Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable Dialysis Start of enrollment: 2015 Jan 15
Completed
Phase 3
Treatment of Uremic Pruritus With PA101B Start of enrollment: 2016 Feb 01
Completed
Phase 2
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) Start of enrollment: 2016 Sep 28
Completed
Phase 3
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID) Start of enrollment: 2017 May 11
Completed
Phase 3
Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents Start of enrollment: 2017 May 02
Terminated
Phase 2
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD) Start of enrollment: 2018 Sep 05
Completed
Phase 3
CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus Start of enrollment: 2019 May 06
Completed
Phase 3
Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease Start of enrollment: 2019 Jun 11
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

A Randomized Trial of the Impact of Ferric Citrate on Erythropoietin and Intravenous Iron Use in Patients Receiving Dialysis.
Geoffrey A Block, Mohammed Reza Mizani, Varshasb Broumand, F David Newby, Ayodele Erinle
American Journal of Nephrology. 2024-01-01
An Arterial Anastomosis Stenosis Used in Lieu of Banding to Prevent Dialysis Access Steal Syndrome.
Juliana N Young, Cynthia A Reyes, Ayodele O Erinle
Cureus. 2022-05-01
23 citations
Saw palmetto-induced pancreatitis.
Ismaila Jibrin, Ayodele Erinle, Abdulfattah Saidi, Zakari Y Aliyu
Southern Medical Journal. 2006-06-01

Professional Memberships

American College of Physicians - ACP
Fellow
American Society of Nephrology - ASN
Member